Primary sclerosing cholangitis (PSC) is a rare progressive liver disease that damages bile ducts and significantly increases the risk of bile duct cancer, particularly a type called cholangiocarcinoma ...
Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Quantitative magnetic resonance cholangiopancreatography may help assess changes in the biliary tree ...
The rare disorder only strikes about 1-2 people per 100,000 in the United States. It is strongly associated with inflammatory ...
"Future guidelines panels could review these results and consider recommending the inclusion of immunotherapy with chemotherapy for the first-line treatment of advanced biliary tract cancer in the ...
Clinically diagnosed pruritus significantly affected fatigue and antidepressant use in adults with primary sclerosing cholangitis (PSC), based on data from nearly 5000 patients presented at The Liver ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window In the U.S., ...
No parent should ever outlive their children. A couple of years ago, my son, who is now approaching 54 years young, was ...
Primary sclerosing cholangitis (PSC) is a rare, chronic cholestatic liver disease of uncertain etiology characterized by the destruction of the intrahepatic and/or extrahepatic ducts through ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that Hepatology Communications published data from the CAMEO study evaluating the safety, tolerability, ...
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), April 28, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results